The global cardiovascular and soft tissue repair patches market was valued at USD 5.18 Billion in 2025, driven by the rising prevalence of cardiovascular and chronic diseases, and the development of the healthcare sector across the globe. The market is anticipated to grow at a CAGR of 7.90% during the forecast period of 2026-2035 to achieve a value of USD 11.08 Billion by 2035.
Base Year
Historical Period
Forecast Period
The increasing collaboration between established market players, pharmaceutical companies, and raw material suppliers is driving the development of novel technologies and innovative products using tissue-engineered materials, shaping the market.
Abdominal wall hernias are among the most prevalent hernias across all age groups. The rising incidence of umbilical, congenital diaphragmatic, inguinal, and ventral hernias is expected to boost demand for repair patches.
The growing geriatric population is a key market driver, as older adults are more susceptible to cardiovascular and gastrointestinal conditions, increasing the need for effective repair solutions.
Compound Annual Growth Rate
7.9%
Value in USD Billion
2026-2035
*this image is indicative*
Cardiovascular and soft tissue repair patches are specialised medical devices designed to support tissue regeneration and healing in cardiac and soft tissue procedures. These patches, made from biological or synthetic materials, are used in surgeries to reinforce weakened or damaged tissues, such as in congenital heart defects, vascular repairs, and hernia treatments. They promote cell integration, reducing complications and improving patient outcomes. With advancements in biomaterials and regenerative medicine, these patches offer enhanced biocompatibility, durability, and adaptability, making them essential in cardiovascular and reconstructive surgeries worldwide.
Advanced Biomaterial Innovations to Drive Market Growth
The rising demand for biocompatible and multifunctional soft tissue repair patches is driven by increasing surgical procedures and advancements in biomaterial technology. The need for patches that reduce post-surgical adhesions, enhance healing, and lower inflammation is a key market driver. For instance, in May 2024, researchers introduced a Janus nanofibrous patch (J-NFP) with anti-adhesion, reactive oxygen species (ROS) scavenging, and pro-healing properties. Developed using sequential electrospinning and polymer grafting, the patch significantly reduces friction, protein adhesion, and inflammation while promoting tissue regeneration. This breakthrough is expected to expand the cardiovascular and soft tissue repair patches market, offering next-generation solutions for post-surgical healing and driving technological advancements in regenerative medicine over the forecast period.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
"Cardiovascular and Soft Tissue Repair Patches Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Material Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Biomaterials to Lead the Segmentation by Material Type
Biomaterial-based patches are poised to dominate the market due to their superior biocompatibility, reduced risk of immune rejection, and enhanced regenerative properties. These patches integrate seamlessly with native tissues, promoting faster healing while minimising complications. As per the analysis by Expert Market Research, the global biomaterial market is likely to grow further at a CAGR of 14.10% during the forecast period of 2025-2034. Advancements in decellularized and bioengineered materials have further increased their adoption in cardiovascular and soft tissue procedures. The growing preference for biological over synthetic materials, coupled with increasing R&D investments in biomaterial innovation, is expected to drive market expansion, ensuring improved surgical outcomes and long-term patient benefits.
Vascular Repair to Lead the Cardiovascular and Soft Tissue Repair Patches Market Segmentation by Application
Vascular repair is anticipated to hold the largest market share, driven by the rising prevalence of cardiovascular diseases, including aneurysms, arterial blockages, and congenital heart defects. The increasing number of vascular surgeries, particularly among the ageing population and patients with lifestyle-related disorders, is fuelling demand for effective repair solutions. Advanced vascular patches with improved flexibility, durability, and biocompatibility are enhancing surgical outcomes. Additionally, technological advancements such as 3D bioprinted vascular grafts and minimally invasive vascular repair techniques are further propelling market growth, making vascular repair the most dominant application segment in the forecast period.
Hospitals to Hold a Substantial Cardiovascular and Soft Tissue Repair Patches Market Share by End User
Hospitals are expected to dominate the market due to their extensive infrastructure, availability of advanced surgical equipment, and a high volume of complex cardiovascular and soft tissue repair procedures. The growing burden of cardiovascular diseases, rising patient admissions, and an increasing number of surgical interventions are boosting demand for high-quality repair patches in hospital settings. Additionally, government funding, technological advancements, and collaborations between hospitals and medical device manufacturers are driving innovations in surgical techniques. With a continuous focus on improving patient outcomes and expanding healthcare accessibility, hospitals will remain the primary end user, significantly influencing market growth.
North America is projected to hold the largest market share, driven by its advanced healthcare infrastructure, strong presence of key industry players, and high adoption of cutting-edge surgical technologies. The United States leads in cardiac and soft tissue procedures, supported by extensive R&D funding and favourable reimbursement policies. Europe follows closely, benefiting from increasing regulatory approvals and government initiatives promoting biomaterial-based patches. Asia Pacific is witnessing rapid growth due to rising medical tourism, improving healthcare accessibility, and expanding manufacturing capabilities.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1984 and headquartered in Kennesaw, Georgia, USA, CryoLife, Inc. is a leading medical device company specialising in cardiovascular and soft tissue repair solutions. The company focuses on the development and commercialisation of implantable human tissues, surgical adhesives, and prosthetic heart valves. CryoLife’s portfolio includes biological patches for vascular and cardiac repair, along with advanced haemostatic sealants for surgical applications. With a strong emphasis on innovation and research, CryoLife continues to enhance patient outcomes by providing high-quality, life-saving medical technologies to healthcare institutions worldwide.
Headquartered in Irvine, California, USA, Edwards Lifesciences Corporation was founded in 1958 and is a global leader in structural heart disease treatments and critical care monitoring. The company specialises in heart valve replacement therapies, including pericardial patches for cardiovascular repair. Edwards Lifesciences' extensive product portfolio includes transcatheter and surgical heart valves, tissue-engineered repair patches, and haemodynamic monitoring solutions. With continuous advancements in cardiac surgery, the company plays a key role in improving patient survival and quality of life, focusing on innovation, clinical leadership, and patient-centric healthcare solutions.
Bard Peripheral Vascular Inc., a subsidiary of Becton, Dickinson and Company (BD), is headquartered in Tempe, Arizona, USA. The company has been a pioneer in vascular surgery solutions, offering an extensive range of products, including vascular grafts, surgical patches, and haemodialysis access solutions. With a strong focus on peripheral vascular disease treatment, Bard Peripheral Vascular provides high-quality biomaterial-based patches for arterial and venous repair. Through continuous innovation and collaboration with healthcare professionals, the company aims to improve patient outcomes in cardiovascular and soft tissue repair procedures.
Established in 1931 and headquartered in Deerfield, Illinois, USA, Baxter International Inc. is a global leader in healthcare, offering innovative medical devices, pharmaceuticals, and biotechnology solutions. The company’s portfolio includes advanced haemostatic agents, biological patches for cardiovascular and soft tissue repair, and surgical sealants. Baxter focuses on improving surgical efficiency and patient recovery through its cutting-edge biomaterials and regenerative medicine products. With a strong presence across hospitals and healthcare institutions worldwide, Baxter continues to drive advancements in surgical care through research-driven solutions and medical technology innovation.
Anteris Technologies Limited, headquartered in Brisbane, Australia, was founded in 1999 and specialises in regenerative medicine and structural heart solutions. The company focuses on the development of next-generation biomaterials and tissue-engineered patches for cardiovascular repair. Its flagship offerings include advanced pericardial patches and implantable cardiac devices designed to enhance heart valve performance and durability. With a strong commitment to innovation and patient-centred research, Anteris Technologies is at the forefront of developing novel solutions for heart valve disease, significantly contributing to the advancement of cardiovascular care worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Shockwave Medical, Inc., Southern Lights Biomaterials (Collagen Solutions), Medtronic Plc, GETINGE AB, W. L. Gore & Associates, Inc., LeMaitre Vascular Inc., and B. Braun Melsungen AG.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Material Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share